Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sobeu Bio is a South Korean biotechnology company specializing in the development of advanced exosome-based therapeutics and high-performance cosmeceuticals. The company leverages a proprietary platform for the isolation and engineering of high-purity exosomes derived from various biological sources to address unmet needs in dermatology and regenerative medicine. Its primary research focus includes treatments for atopic dermatitis, hair loss (alopecia), and skin rejuvenation. By utilizing exosomes as natural delivery vehicles for bioactive molecules, Sobeu Bio aims to provide targeted, low-toxicity solutions for inflammatory and degenerative conditions. The company is currently advancing its pipeline through pre-clinical studies while commercializing exosome-enhanced skincare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SOBEU.